CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes

Oliver Schnell; Tadej Battelino; Richard Bergenstal; Andreas L. Birkenfeld; Antonio Ceriello; Alice Cheng; Melanie Davies; Steve Edelman; Thomas Forst; Francesco Giorgino; Jennifer Green; Per-Henrik Groop; Samy Hadjadj; Hiddo J. L. Heerspink; Marcus Hompesch; Baruch Izthak; Linong Ji; Naresh Kanumilli; Boris Mankovsky; Chantal Mathieu; Martin Miszon; Reem Mustafa; Michael Nauck; Roberto Pecoits-Filho; Jeremy Pettus; Kari Ranta; Helena W. Rodbard; Peter Rossing; Lars Ryden; Petra-Maria Schumm-Draeger; Scott D. Solomon; Jan Skrha; Pinar Topsever; Tina Vilsboll; John Wilding; Eberhard Standl

doi:10.1186/s12933-023-01788-6

CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes

Oliver Schnell, Tadej Battelino, Richard Bergenstal, Andreas L. Birkenfeld, Antonio Ceriello, Alice Cheng, Melanie Davies, Steve Edelman, Thomas Forst, Francesco Giorgino, Jennifer Green, Per-Henrik Groop, Samy Hadjadj, Hiddo J. L. Heerspink, Marcus Hompesch, Baruch Izthak, Linong Ji, Naresh Kanumilli, Boris Mankovsky, Chantal MathieuMartin Miszon, Reem Mustafa, Michael Nauck, Roberto Pecoits-Filho, Jeremy Pettus, Kari Ranta, Helena W. Rodbard, Peter Rossing, Lars Ryden, Petra-Maria Schumm-Draeger, Scott D. Solomon, Jan Skrha, Pinar Topsever, Tina Vilsboll, John Wilding, Eberhard Standl

Tutkimustuotos: Artikkelijulkaisu › Kommentti › Tieteellinen

Alkuperäiskieli	englanti
Lehti	Cardiovascular Diabetology
Vuosikerta	22
Numero	1
Sivumäärä	12
ISSN	1475-2840
DOI - pysyväislinkit	https://doi.org/10.1186/s12933-023-01788-6
Tila	Julkaistu - 16 maalisk. 2023
OKM-julkaisutyyppi	B1 Kirjoitus tieteellisessä aikakauslehdessä

Tieteenalat

Cardiovascular disease
Chronic kidney disease
Diabetes
GIP/GLP-1 receptor agonist
Heart failure
Obesity
SGLT2 inhibitor
3121 Yleislääketiede, sisätaudit ja muut kliiniset lääketieteet

Pääsy asiakirjaan

10.1186/s12933-023-01788-6Lisenssi: CC BY

s12933-023-01788-6 (1)Lopullinen julkaistu versio, 798 KBLisenssi: CC BY

Siteeraa tätä

Schnell, O., Battelino, T., Bergenstal, R., Birkenfeld, A. L., Ceriello, A., Cheng, A., Davies, M., Edelman, S., Forst, T., Giorgino, F., Green, J., Groop, P.-H., Hadjadj, S., Heerspink, H. J. L., Hompesch, M., Izthak, B., Ji, L., Kanumilli, N., Mankovsky, B., ... Standl, E. (2023). CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes. Cardiovascular Diabetology, 22(1). https://doi.org/10.1186/s12933-023-01788-6

@article{b1913af7d4ee4062a352dc0fe9353358,

title = "CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes",

keywords = "Cardiovascular disease, Chronic kidney disease, Diabetes, GIP/GLP-1 receptor agonist, Heart failure, Obesity, SGLT2 inhibitor, 3121 General medicine, internal medicine and other clinical medicine",

author = "Oliver Schnell and Tadej Battelino and Richard Bergenstal and Birkenfeld, {Andreas L.} and Antonio Ceriello and Alice Cheng and Melanie Davies and Steve Edelman and Thomas Forst and Francesco Giorgino and Jennifer Green and Per-Henrik Groop and Samy Hadjadj and Heerspink, {Hiddo J. L.} and Marcus Hompesch and Baruch Izthak and Linong Ji and Naresh Kanumilli and Boris Mankovsky and Chantal Mathieu and Martin Miszon and Reem Mustafa and Michael Nauck and Roberto Pecoits-Filho and Jeremy Pettus and Kari Ranta and Rodbard, {Helena W.} and Peter Rossing and Lars Ryden and Petra-Maria Schumm-Draeger and Solomon, {Scott D.} and Jan Skrha and Pinar Topsever and Tina Vilsboll and John Wilding and Eberhard Standl",

year = "2023",

month = mar,

day = "16",

doi = "10.1186/s12933-023-01788-6",

language = "English",

volume = "22",

journal = "Cardiovascular Diabetology",

issn = "1475-2840",

publisher = "BioMed Central",

number = "1",

}

Schnell, O, Battelino, T, Bergenstal, R, Birkenfeld, AL, Ceriello, A, Cheng, A, Davies, M, Edelman, S, Forst, T, Giorgino, F, Green, J, Groop, P-H, Hadjadj, S, Heerspink, HJL, Hompesch, M, Izthak, B, Ji, L, Kanumilli, N, Mankovsky, B, Mathieu, C, Miszon, M, Mustafa, R, Nauck, M, Pecoits-Filho, R, Pettus, J, Ranta, K, Rodbard, HW, Rossing, P, Ryden, L, Schumm-Draeger, P-M, Solomon, SD, Skrha, J, Topsever, P, Vilsboll, T, Wilding, J & Standl, E 2023, 'CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes', Cardiovascular Diabetology, Vuosikerta 22, Nro 1. https://doi.org/10.1186/s12933-023-01788-6

TY - JOUR

T1 - CVOT Summit 2022 Report

T2 - new cardiovascular, kidney, and glycemic outcomes

AU - Schnell, Oliver

AU - Battelino, Tadej

AU - Bergenstal, Richard

AU - Birkenfeld, Andreas L.

AU - Ceriello, Antonio

AU - Cheng, Alice

AU - Davies, Melanie

AU - Edelman, Steve

AU - Forst, Thomas

AU - Giorgino, Francesco

AU - Green, Jennifer

AU - Groop, Per-Henrik

AU - Hadjadj, Samy

AU - Heerspink, Hiddo J. L.

AU - Hompesch, Marcus

AU - Izthak, Baruch

AU - Ji, Linong

AU - Kanumilli, Naresh

AU - Mankovsky, Boris

AU - Mathieu, Chantal

AU - Miszon, Martin

AU - Mustafa, Reem

AU - Nauck, Michael

AU - Pecoits-Filho, Roberto

AU - Pettus, Jeremy

AU - Ranta, Kari

AU - Rodbard, Helena W.

AU - Rossing, Peter

AU - Ryden, Lars

AU - Schumm-Draeger, Petra-Maria

AU - Solomon, Scott D.

AU - Skrha, Jan

AU - Topsever, Pinar

AU - Vilsboll, Tina

AU - Wilding, John

AU - Standl, Eberhard

PY - 2023/3/16

Y1 - 2023/3/16

KW - Cardiovascular disease

KW - Chronic kidney disease

KW - Diabetes

KW - GIP/GLP-1 receptor agonist

KW - Heart failure

KW - Obesity

KW - SGLT2 inhibitor

KW - 3121 General medicine, internal medicine and other clinical medicine

U2 - 10.1186/s12933-023-01788-6

DO - 10.1186/s12933-023-01788-6

M3 - Comment/debate

C2 - 36927451

SN - 1475-2840

VL - 22

JO - Cardiovascular Diabetology

JF - Cardiovascular Diabetology

IS - 1

ER -